Wisdom Health acquires genetics research firm Optigen, LLC.
WISDOM PANEL Health breed + disease test for consumers is introduced.
Mars Veterinary changes their business name to Wisdom HealthTM.
Wisdom Health acquires leading Finnish research and diagnostics company, Genoscoper™ Laboratories.
WISDOM PANEL 4.0 testing with the addition of trait analysis and EIC screening is launched.
OPTIMAL SELECTIONTM test for feline breeders is launched making it the first panel disease and trait test for felines on the market.
A Division of Mars Petcare completes the transition of Mars Veterinary into the Mars Petcare segment.
WISDOM PANEL 2.5 and 3.0 are launched into the consumer channel featuring MDR1 testing.
Banfield CTS headquarters becomes the permanent home of the Mars Veterinary Business unit.
WISDOM PANEL 2.0 is launched into the consumer channel.
WISDOM PANEL Insights is launched into the consumer channel.
WISDOM PANEL MX TM is launched into the U.S. veterinary channel.
A Division of Mars Symbioscience is formed and Mars Veterinary becomes part of the Symbioscience incubator segment based at Nottingham Laboratory.
The Breed Determination Patent is licensed from the Fred Hutchinson Cancer Research Center.
Genomics Technology Platform (Profile Technology) is created for researching canine DNA solutions at Waltham and Nottingham University Laboratories.